Equities

Niox Group PLC

NIOX:LSE

Niox Group PLC

Health CareMedical Equipment and Services
  • Price (GBX)73.80
  • Today's Change0.60 / 0.82%
  • Shares traded231.04k
  • 1 Year change24.66%
  • Beta1.3244
Data delayed at least 20 minutes, as of May 20 2024 16:35 BST.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 16-May-24
Select bar for recommendation details.
Recommendations16-May-24
Buy1
Outperform3
Hold1
Underperform0
Sell0

Share price forecast

The 5 analysts offering 12 month price targets for Niox Group PLC have a median target of 77.00, with a high estimate of 90.00 and a low estimate of 63.00. The median estimate represents a 5.19% increase from the last price of 73.20.
High23.0%90.00
Med5.2%77.00
Low-13.9%63.00

Dividends

In 2023, Niox Group PLC reported a dividend of 0.01 GBP. The 4 analysts covering the company expect dividends of 0.01 GBP for the upcoming fiscal year, an increase of 10.00%.
Div growth (TTM)--
More ▼

Earnings history & estimates

Niox Group PLC reported annual 2023 earnings of 2.38 per share on Mar 26, 2024.
Average growth rate+6,353.66%
More ▼

Revenue history & estimates

Circassia Group Plc had revenues for the full year 2023 of 36.80m. This was 17.57% above the prior year's results.
Average growth rate-3.80%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.